Home
>
National Drug Code (NDC)
>
LANOXIN
LANOXIN - 0173-0249-55 - (digoxin)
Drug Information of LANOXIN
| Product NDC: | 0173-0249 |
| Proprietary Name: | LANOXIN |
| Non Proprietary Name: | digoxin |
| Active Ingredient(s): | 250 ug/1 & nbsp; digoxin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LANOXIN
| Product NDC: | 0173-0249 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020405 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19840702 |
Package Information of LANOXIN
| Package NDC: | 0173-0249-55 |
| Package Description: | 100 TABLET in 1 BOTTLE (0173-0249-55) |
NDC Information of LANOXIN
| NDC Code | 0173-0249-55 |
| Proprietary Name | LANOXIN |
| Package Description | 100 TABLET in 1 BOTTLE (0173-0249-55) |
| Product NDC | 0173-0249 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | digoxin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19840702 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | DIGOXIN |
| Strength Number | 250 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |
